> top > docs > PMC:7253482 > spans > 221-391 > annotations

PMC:7253482 / 221-391 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
33 146-151 Gene denotes spike Gene:43740568

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 156-168 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 65-72 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 156-168 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T2 117-140 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 125-140 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T32 1-5 JJ denotes high
T33 6-14 NN denotes fatality
T34 15-20 NNS denotes rates
T35 21-24 CC denotes and
T36 25-33 JJ denotes pandemic
T37 34-43 NN denotes potential
T38 45-52 NN denotes Vaccine
T39 53-64 NN denotes development
T40 65-72 VBZ denotes focuses
T41 73-75 IN denotes on
T42 76-79 DT denotes the
T43 80-89 JJ denotes principal
T44 90-96 NN denotes target
T45 97-99 IN denotes of
T46 100-103 DT denotes the
T47 104-116 VBG denotes neutralizing
T48 117-124 JJ denotes humoral
T49 125-131 JJ denotes immune
T50 132-140 NN denotes response
T51 140-141 -COMMA- denotes ,
T52 142-145 DT denotes the
T53 146-151 NN denotes spike
T54 152-153 -LRB- denotes (
T55 153-154 NN denotes S
T56 154-155 -RRB- denotes )
T57 156-168 NN denotes glycoprotein
R30 T34 T32 arg1Of rates,high
R31 T34 T33 arg1Of rates,fatality
R32 T34 T35 arg1Of rates,and
R33 T37 T35 arg2Of potential,and
R34 T37 T36 arg1Of potential,pandemic
R35 T39 T38 arg1Of development,Vaccine
R36 T39 T40 arg1Of development,focuses
R37 T40 T41 arg1Of focuses,on
R38 T44 T41 arg2Of target,on
R39 T44 T42 arg1Of target,the
R40 T44 T43 arg1Of target,principal
R41 T44 T45 arg1Of target,of
R42 T50 T45 arg2Of response,of
R43 T50 T46 arg1Of response,the
R44 T50 T47 arg1Of response,neutralizing
R45 T50 T48 arg1Of response,humoral
R46 T50 T49 arg1Of response,immune
R47 T50 T51 arg1Of response,","
R48 T57 T51 arg2Of glycoprotein,","
R49 T57 T52 arg1Of glycoprotein,the
R50 T57 T53 arg1Of glycoprotein,spike
R51 T53 T54 arg1Of spike,(
R52 T55 T54 arg2Of S,(
R53 T56 T54 arg3Of ),(

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 156-168 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 156-168 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T4 45-169 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
33 146-151 Gene denotes spike Gene:43740568

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 152-168 Protein denotes (S) glycoprotein https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T2 117-140 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 125-140 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T2 117-140 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 125-140 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T2 117-140 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 125-140 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 45-169 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.